Posted by Gary Greenberg It’s been just over twenty-five years since Prozac came to market, and more than twenty per cent of Americans now regularly take mind-altering drugs prescribed by their doctors. Almost as familiar as brands like… Read More ›
AstraZeneca
‘Medical stocks are down by 90 percent’: Greece accuses pharma giants of slashing imports
Published time: February 28, 2013 01:36 AFP Photo / Louisa Gouliamaki The Greek government has reportedly accused 50 leading pharmaceutical companies of cutting off supplies of key medications to the country, sparking a run on pharmacies. Drug companies say… Read More ›
GAO: FDA fails to follow up on unproven drugs ” FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits”
2009 report posted for filing By MATTHEW PERRONE, AP Business Writer Matthew Perrone, Ap Business Writer WASHINGTON – The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when… Read More ›
Most heart attack patients’ cholesterol levels did not indicate cardiac risk: half of the patients with a history of heart disease had LDL cholesterol levels lower than 100 mg/dL
Contact: Rachel Champeau rchampeau@mednet.ucla.edu 310-794-2270 University of California – Los Angeles A new national study has shown that nearly 75 percent of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk… Read More ›
Only 15% of Whistleblower Off Label Drug Complaints have Adequate Financial Disclosure
Contact: Sumrina Yousufzai syousufzai@plos.org 415-568-3164 Public Library of Science COI declarations and off-label drug use Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label… Read More ›
Drug company funding of drug trials greatly influences outcome – 35x Better Outcome if Funded by the Drug Company
Contact: Wallace Ravven wravven@pubaff.ucsf.edu 415-476-2557 University of California – San Francisco Drug company funding of drug trials greatly influences outcome In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study,… Read More ›
Engineering Evil 